Log in to save to my catalogue

Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal...

Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_42ff2385ab36479d9999c122c50772bb

Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study

About this item

Full title

Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study

Publisher

MDPI AG

Journal title

Current oncology (Toronto), 2023-10, Vol.30 (10), p.9090-9103

Language

English

Formats

Publication information

Publisher

MDPI AG

More information

Scope and Contents

Contents

Uveal melanoma is the most common primary intraocular malignancy in adults. Up to 50% of UM patients develop metastatic disease, usually in the liver. When metastatic, the prognosis is poor, and few treatment options exist. Here, we investigated the feasibility of establishing patient-derived xenografts (PDXs) from a patient’s tumor in order to scr...

Alternative Titles

Full title

Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_42ff2385ab36479d9999c122c50772bb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_42ff2385ab36479d9999c122c50772bb

Other Identifiers

ISSN

1718-7729,1198-0052

E-ISSN

1718-7729

DOI

10.3390/curroncol30100657

How to access this item